IDA International 1A
- Eligible for a tax reduction
Levent Akar
CEO
Levent is sales and management executive worked in a multinational companies with 15 years of experience in the life science industry across different regions. He founded a distributor company 13 years ago and achieved significant sales numbers in Türkiye. He also founded an R&D company 5 years ago achived several knowhow of protein manufacturing. His aim is to transfer this knowhow to IDA and position as a key player in the global life science industry.
Levent holds BS in chemistry and MS in medical biology and genetics.
https://www.linkedin.com/in/levent-akar-b249a121/
Kaan Türkgeldi
Sales
Kaan has extensive expertise in sales field. He has worked in sales and marketing departments in Türkiye for more than 5 yers. His aim to support IDA for internationalization today.
Kaan holds BA degree in Bioengineering and MS degree in Occupational Health and Safety,
https://www.linkedin.com/in/kaan-t%C3%BCrkgeldi-04943a80/
Assoc.Prof.Mehmet Nuri İnel
Advisor
Mehmet consults and trains as especially the blending of market expectations and academic knowledge; about Business development analytics, digitalization, Industry 4.0, Big Data, Management with data, decision making, process analysis improvement and development, problem solving techniques, problem solving analytics, research design and analysis topics. He gives a speech for some summits and companies about his researches and interests. https://www.linkedin.com/in/do%C3%A7-dr-mehmet-nuri-inel-985362a3/
Melike Oyuncakçı
Staff
Melike has MS on Molecular Biology and Genetics having experience on antibody production and development with antibody production processes, establishing cell lines, and use protein purification techniques to develop high-yield antibody production systems.
https://www.linkedin.com/in/melike-oyuncakci-8a3300161/
TAX SHELTER 45%
Investments in this company benefit from a 45% personal income tax reduction. Read more…Raise summary
| Crowd investments | €500 |
| Committed by others | €0 |
| Amount raised | €500 |
| Minimum round | €25,000 |
| Maximum round | €400,000 |
| Shares in the company (total round) | 9.091% |
| Pre-money valuation | €4,000,000 |
| Post-money valuation min. | €4,025,000 |
| Post-money valuation max. | €4,400,000 |